Latest updates related to Stroke and pulmonary embolism

Stroke is a leading cause of death and disability. Medical complications after ischemic stroke contribute substantially to poor stroke outcomes. 

Pulmonary embolism (PE) is a serious medical condition whose annual incidence rate of 0.50 to 0.69 per 1000 persons in the general population. The high mortality rate of PE with case fatality at 3 months ranging between 8.6% and 17%.

Longer‐term mortality rate can be as high as 24%. The risk of pulmonary embolism, including fatal cases, in patients with acute ischemic stroke (AIS) is well known.

Studies have suggested that an increased risk of stroke among patients with acute pulmonary embolism (PE) which is thought to be due to paradoxical embolism via a patent foramen ovale (PFO). In a recent prospective study of patients with acute PE, stroke was diagnosed in 8 percent (8%), with a higher rate (21 percent) among those with a PFO. However, the exclusion of some patients from the analysis and a lower-than-expected rate of PFO than in the general population suggest that these results may be flawed. There are some limitations in available data, routinely contrast echocardiography not performing (transthoracic or transesophageal) or brain imaging in patients with acute PE, but rather adopt a symptom-directed approach to imaging. 

x

Premature mortality due to traumatic brain injury in England and wales over a 10 year period

Traumatic Brain Injury (TBI) is increasingly being appreciated as a global public health and socio-economic concern. In the United Kingdom the economic burden of TBI has been estimated to be >£15 billion per year from premature death and impact on survivors. Premature mortality can be quantified as the potential years of life lost (PYLL) and – when compared across diseases - can inform decisions on resource allocation for prevention, clinical care and research.

Traumatic brain injury (TBI), also described as head injury is any injury to the brain caused by impact, for example, a direct blow to the head or a force that causes the brain to move around inside the skull. Common causes are falls, road accidents, collisions and violence. Head injuries vary greatly in severity, depending on whether and for how long they result in a loss of consciousness or post-traumatic amnesia. About 10-15% of all TBIs are classified as moderate or severe and the remaining 85- 90% as mild.

TBI was implicated in 33,006 deaths over this period, accounting for 561,000 PYLL before the age of 65. The cerebrovascular disease had a lower PYLL before the age of 65 (318,000), despite having a significantly higher total number of deaths (404,017) over the same period.
Over the 10 year period, we estimate the ‘lost productivity’ due to fatal TBIs alone to be £5.3 billion.  

Traumatic Brain Injury by age group

Latest Global Neurology EMR Software Market Research Report 2019-2025

The latest study of Global Neurology EMR Software Market Report provides context, prophecy and detailed information on the neurology EMR software industry with definitions, classification, applications, industry chain structure, industry overview; Analysis of the international market.

The Neurology EMR Software Market Report explores the market sales of the EMR neurological software market and focuses on the main suppliers by identifying the volume, price, revenue and market share of each region in terms of volume and price.

This research report from Neurology EMR Software includes development trends, competitive landscape analysis, key regions development status and summary of trends that can help companies operating in the industry understand the market and develop strategies for their business expansion accordingly. The research report analyzes the size of the market, participation in the industry, growth, key segments, CAGR and key drivers.

Neurologists 2019 Highlights

• Neurons and Neurology
• Neurosurgery and spine surgery
• Neuroscience
• Neurologists
• Mental Health: Alzheimer’s Disease and Dementia
• Parkinson’s Disease
• Huntington’s Disease
• Stroke and Neurological Disorders
• Neuropsychology, Neuropharmacology and Neurochemistry
• Central Nervous System
• Neuropsychiatry and Clinical Neurology
• Neuroimmunology and Neurotransmitters
• Epilepsy and its Treatment
• Brain Tumours & Neuro Oncology
• Neuromuscular and cognitive Disorders
• Anxiety and Depression
• Neuro-Ophthalmology and sleep disorders
• Neuroimaging and Radiology techniques
• Novel Neurotherapeutics and Diagnostics
• Neuropediatrics and Neurorehabilitation
• Case Reports on Neurology & Neurosurgery